BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27095322)

  • 1. A metabolic syndrome severity score: A tool to quantify cardio-metabolic risk factors.
    Wiley JF; Carrington MJ
    Prev Med; 2016 Jul; 88():189-95. PubMed ID: 27095322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between metabolic syndrome severity and the risk of mortality in gout patients: a population-based study.
    Schlesinger N; Elsaid MI; Rustgi VK
    Clin Exp Rheumatol; 2022 Mar; 40(3):631-633. PubMed ID: 35238754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome severity score (MetSSS) associates with metabolic health status in multi-ethnic Aotearoa New Zealand cohorts.
    Merry TL; Metcalf P; Scragg R; Gearry R; Foster M; Krebs JD
    Diabetes Res Clin Pract; 2022 Oct; 192():110088. PubMed ID: 36154929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Potential of a Novel Metabolic Syndrome Severity Score to Inform Exercise Interventions for People with Complex Chronic Conditions.
    Brown RCC; Coombes JS; Conley MM; Webb L; Mayr HL; Isbel NM; Jegatheesan DK; Macdonald GA; Burton NW; Kelly JT; Hickman IJ; Keating SE
    Metab Syndr Relat Disord; 2024 May; ():. PubMed ID: 38801006
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
    Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
    J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Risk Stratification in Patients with Metabolic Syndrome Without Diabetes or Cardiovascular Disease: Usefulness of Metabolic Syndrome Severity Score.
    Masson W; Epstein T; Huerín M; Lobo LM; Molinero G; Angel A; Masson G; Millán D; De Francesca S; Vitagliano L; Cafferata A; Losada P
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):297-303. PubMed ID: 28502055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Diet and Cardio-Metabolic Risk on Cognitive Performance: A Cross-Sectional Study of Middle-Aged Australian Adults.
    Gauci S; Young LM; Arnoldy L; Scholey A; White DJ; Lassemillante AC; Meyer D; Pipingas A
    Front Nutr; 2022; 9():862475. PubMed ID: 35571882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A health outcome assessment of the Cardio Metabolic Mission Health Program at Novartis.
    Mauceri E; Bienkowski C; Hanson KA; Doyle JJ; Jackson J; Bramer S
    J Occup Environ Med; 2011 Jun; 53(6):647-52. PubMed ID: 21654435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and interrelationships between cardio-metabolic risk factors in abdominally obese individuals.
    Pettman TL; Buckley JD; Coates AM; Misan GM; Petkov J; Howe PR
    Metab Syndr Relat Disord; 2009 Feb; 7(1):31-6. PubMed ID: 19025446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life.
    Christ SM; Schettle M; Willmann J; Ahmadsei M; Seiler A; Blum D; Guckenberger M; Andratschke N; Hertler C
    Clin Transl Radiat Oncol; 2022 May; 34():107-111. PubMed ID: 35496816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis.
    Nieder C; Mannsåker B; Yobuta R
    Cureus; 2022 Jan; 14(1):e21223. PubMed ID: 35174028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cardiovascular risk factors in patients with psoriasis.
    Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
    J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease.
    Hughes JT; O'Dea K; Piera K; Barzi F; Cass A; Hoy WE; MacIsaac RJ; Maple-Brown LJ
    Obes Res Clin Pract; 2016; 10(6):659-672. PubMed ID: 26669799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who is at risk of chronic disease? Associations between risk profiles of physical activity, sitting and cardio-metabolic disease in Australian adults.
    Engelen L; Gale J; Chau JY; Hardy LL; Mackey M; Johnson N; Shirley D; Bauman A
    Aust N Z J Public Health; 2017 Apr; 41(2):178-183. PubMed ID: 27960249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waist-to-height ratio, body mass index and waist circumference for screening paediatric cardio-metabolic risk factors: a meta-analysis.
    Lo K; Wong M; Khalechelvam P; Tam W
    Obes Rev; 2016 Dec; 17(12):1258-1275. PubMed ID: 27452904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Implications of Diabetes, Metabolic Syndrome, Thyroid Disease, and Cardio-Oncology in Women.
    Tadic M; Cuspidi C; Vasic D; Kerkhof PLM
    Adv Exp Med Biol; 2018; 1065():471-488. PubMed ID: 30051402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.